Health
New breast cancer gene can predict likelihood of hereditary disease, study finds
Some danger elements for breast most cancers — equivalent to food plan, train or hormone drugs — are preventable. However others, like sure genetic mutations, can’t be modified.
It’s already identified that some genes can predict the chance of breast most cancers. Girls with a mutation within the BRCA1 or BRCA2 gene, for instance, have a 70% danger of growing the illness, in line with the American Most cancers Society.
Now, in what they’re describing as a landmark research revealed in The American Journal of Human Genetics on Monday, researchers have recognized a brand new gene that predicts the chance of hereditary breast most cancers.
OHIO WOMAN PUSHES PAST BREAST CANCER, WON’T LET DIAGNOSIS SLOW HER DOWN
Individuals who have mutations in a gene known as ATRIP are at a considerably greater danger of growing the illness, researchers mentioned.
ATRIP mutations, although, aren’t as prevalent as those that may happen within the BRCA1 or BRCA2 genes.
The ATRIP gene’s job is to stop one thing known as replicative stress, which is an enormous driver of most cancers improvement.
That is in line with Dr. Jenn Simmons, a practical drugs doctor and integrative oncologist at Actual Well being MD in King of Prussia, Pennsylvania, defined to Fox Information Digital.
“In different phrases, when a cell duplicates, this gene protects in opposition to errors at that stage,” Simmons informed Fox Information Digital (she was not concerned within the research). “Somebody with the ATRIP gene mutation shall be extra vulnerable to those replicating errors.”
FDA ISSUES NEW MAMMOGRAM REGULATIONS AIMED AT FURTHER BREAST CANCER PREVENTION
Genes, nonetheless, are just one a part of the equation, she added. Surroundings and way of life well being additionally play a task within the end result.
Research targeted on Polish ladies with household historical past
The research’s analysis crew — led by Dr. Mohammad Reza Akbari, Girls’s Faculty Hospital scientist and an affiliate professor on the College of Toronto — found ATRIP when performing genetic testing on a bunch of ladies in Poland who had a household historical past of breast most cancers.
About 10% of all breast most cancers circumstances are hereditary.
Subsequent, the researchers analyzed a bigger group of Polish ladies with breast most cancers. Additionally they studied genetic knowledge from breast most cancers sufferers within the U.Ok. Biobank, a big database containing medical data from 500,000 U.Ok. members.
“We all know that genetics play an necessary position within the chance of growing breast most cancers, with hereditary breast most cancers accounting for roughly 10% of all circumstances,” mentioned Akbari in a press launch saying the findings.
“Now that ATRIP has been recognized, extra households will be capable of get the solutions they deserve.”
“This analysis highlights how necessary it’s for physicians to take an in depth household historical past for all people to study their danger elements, and to tell suggestions concerning genetic counseling and additional testing,” Dr. Monique Gary, medical director of the most cancers program at Grand View Well being in Sellersville, Pennsylvania, informed Fox Information Digital.
“The implications are necessary not only for danger evaluation and discount, however to additionally assess therapy choices that will particularly goal germline mutations,” added Dr. Gary, who was not concerned within the research.
She mentioned the data gained within the research probably may enhance remedies and lift survival charges.
Outcomes are promising, but extra analysis is required
Though these findings may mark an necessary step in understanding the hereditary and genetic causes of breast most cancers, Dr. Gary famous that the analysis continues to be in its early phases.
“Given the homogeneity of the members assessed, we must also proceed to advance analysis in populations the place there’s a greater burden of illness and mortality to know why these disparities exist,” she mentioned.
“Now that ATRIP has been recognized, extra households will be capable of get the solutions they deserve.”
Louise Morrell, M.D., medical director of Lynn Most cancers Institute, a part of Baptist Well being South Florida, identified that the research has two key limitations.
“First, the writer acknowledges that it is a small inhabitants that has a really comparable genetic background,” she informed Fox Information Digital.
“A research of bigger populations will assist validate these findings.”
BREAST CANCER AND MAMMOGRAMS: EVERYTHING YOU NEED TO KNOW ABOUT THE DISEASE, SCREENING AND MORE
Morrell additionally mentioned extra knowledge is required about this new gene and the extent of elevated danger.
“For instance, BRCA [mutations] trigger a girl to have as much as an 80% danger, however different breast most cancers genes might solely trigger a girl to have a 20% danger,” she mentioned.
With testing strategies all the time evolving, Morrell known as for anybody with a household historical past of cancers to test in with their doctor periodically, even when they examined unfavorable up to now.
The analysis crew believes the brand new discovery will “have a significant influence on all these affected by familial breast most cancers,” nevertheless it plans to proceed extra evaluation of the gene.
“Proper now, we’re screening households in our knowledge financial institution which have familial breast most cancers to see in the event that they match for ATRIP,” Akbari mentioned within the press launch.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“Going ahead, our crew will proceed to analyze additional, leveraging DNA knowledge units throughout the globe to raised perceive ATRIP and its influence.”
Simmons, for her half, is hopeful that discovering genetic mutations such because the one present in ATRIP may lead individuals to take a extra lively position of their well being.
Apart from pores and skin cancers, breast most cancers is the commonest sort amongst U.S. ladies, accounting for about 30% of all new feminine circumstances every year, per the American Most cancers Society.
There may be a couple of 13% likelihood that any given lady will develop breast most cancers in her lifetime.
Health
FDA bans red food dye due to potential cancer risk
The U.S. Food and Drug Administration (FDA) has officially banned red dye — called Red 3, or Erythrosine — from foods, dietary supplements and ingested medicines, as reported by the Associated Press on Wednesday.
Food manufacturers must remove the dye from their products by January 2027, while drug manufacturers will have until January 2028 to do so, AP stated.
Any foods imported into the U.S. from other countries will also be subject to the new regulation.
RED FOOD DYE COULD SOON BE BANNED AS FDA REVIEWS PETITION
“The FDA is taking action that will remove the authorization for the use of FD&C Red No. 3 in food and ingested drugs,” said Jim Jones, the FDA’s deputy commissioner for human foods, in a statement.
“Evidence shows cancer in laboratory male rats exposed to high levels of FD&C Red No.3,” he continued. “Importantly, the way that FD&C Red No. 3 causes cancer in male rats does not occur in humans.”
The synthetic dye, which is made from petroleum, is used as a color additive in food and ingested drugs to give them a “bright cherry-red color,” according to an online statement from the FDA.
The petition to ban the dye cited the Delaney Clause, which states that the agency cannot classify a color additive as safe if it has been found to induce cancer in humans or animals.
The dye was removed from cosmetics nearly 35 years ago due to potential cancer risk.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“This is a welcome, but long overdue, action from the FDA: removing the unsustainable double standard in which Red 3 was banned from lipstick but permitted in candy,” said Dr. Peter Lurie, director of the group Center for Science in the Public Interest, which led the petition effort, as reported by AP.
Dr. Marc Siegel, clinical professor of medicine at NYU Langone Health and Fox News senior medical analyst, applauded the FDA’s ban.
“It was a long time coming,” he told Fox News Digital. “It’s been more than 30 years since it was banned from cosmetics in the U.S. due to evidence that it is carcinogenic in high doses in lab rats. There needs to be a consistency between what we put on our skin and what we put into our mouths.”
“There needs to be a consistency between what we put on our skin and what we put into our mouths.”
Siegel said he believes the FDA’s decision could be tied to the incoming new head of the Department of Health and Human Services, Robert F. Kennedy Jr.
“They knew it would have happened anyway under RFK Jr.,” he said. “It is already banned or severely restricted in Australia, Japan and the European Union.”
The food additive also “drew kids in” to a diet of empty calories and ultraprocessed foods, Siegel added.
“It has also been linked to behavioral issues in children, including ADHD.”
Nearly 3,000 foods are shown to contain Red No. 3, according to Food Scores, a database of foods compiled by the Environmental Working Group.
For more Health articles, visit www.foxnews.com/health
The National Confectioners Association provided the below statement to Fox News Digital.
“Food safety is the number one priority for U.S. confectionery companies, and we will continue to follow and comply with FDA’s guidance and safety standards.”
The petition to remove Red No. 3 from foods, supplements and medications was presented in 2022 by the Center for Science in the Public Interest and 23 other organizations and scientists.
Health
How Yvette Nicole Brown Lost Weight and Got Her Diabetes Under Control
Sign Up
Create a free account to access exclusive content, play games, solve puzzles, test your pop-culture knowledge and receive special offers.
Already have an account? Login
Use left and right arrow keys to navigate between menu items.
Use escape to exit the menu.
Health
As bird flu spreads, CDC recommends faster 'subtyping' to catch more cases
As cases of H5N1, also known as avian flu or bird flu, continue to surface across the U.S., safety precautions are ramping up.
The U.S. Centers for Disease Control and Prevention (CDC) announced on Thursday its recommendation to test hospitalized influenza A patients more quickly and thoroughly to distinguish between seasonal flu and bird flu.
The accelerated “subtyping” of flu A in hospitalized patients is in response to “sporadic human infections” of avian flu, the CDC wrote in a press release.
ONE STATE LEADS COUNTRY IN HUMAN BIRD FLU WITH NEARLY 40 CONFIRMED CASES
“CDC is recommending a shortened timeline for subtyping all influenza A specimens among hospitalized patients and increasing efforts at clinical laboratories to identify non-seasonal influenza,” the agency wrote.
“Clinicians and laboratorians are reminded to test for influenza in patients with suspected influenza and, going forward, to now expedite the subtyping of influenza A-positive specimens from hospitalized patients, particularly those in an intensive care unit (ICU).”
LOUISIANA REPORTS FIRST BIRD FLU-RELATED HUMAN DEATH IN US
The goal is to prevent delays in identifying bird flu infections and promote better patient care, “timely infection control” and case investigation, the agency stated.
These delays are more likely to occur during the flu season due to high patient volumes, according to the CDC.
For more Health articles, visit www.foxnews.com/health
Health care systems are expected to use tests that identify seasonal influenza A as a subtype – so if a test comes back positive for influenza A but negative for seasonal influenza, that is an indicator that the detected virus might be novel.
“Subtyping is especially important in people who have a history of relevant exposure to wild or domestic animals [that are] infected or possibly infected with avian influenza A (H5N1) viruses,” the CDC wrote.
In an HHS media briefing on Thursday, the CDC confirmed that the public risk for avian flu is still low, but is being closely monitored.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
The agency spokesperson clarified that this accelerated testing is not due to bird flu cases being missed, as the CDC noted in its press release that those hospitalized with influenza A “probably have seasonal influenza.”
Niels Riedemann, MD, PhD, CEO and founder of InflaRx, a German biotechnology company, said that understanding these subtypes is an “important step” in better preparing for “any potential outbreak of concerning variants.”
“It will also be important to foster research and development of therapeutics, including those addressing the patient’s inflammatory immune response to these types of viruses – as this has been shown to cause organ injury and death during the COVID pandemic,” he told Fox News Digital.
Since 2022, there have been 67 total human cases of bird flu, according to the CDC, with 66 of those occurring in 2024.
The CDC recommends that people avoid direct contact with wild birds or other animals that are suspected to be infected. Those who work closely with animals should also wear the proper personal protective equipment (PPE).
-
Technology1 week ago
Meta is highlighting a splintering global approach to online speech
-
Science6 days ago
Metro will offer free rides in L.A. through Sunday due to fires
-
Technology1 week ago
Las Vegas police release ChatGPT logs from the suspect in the Cybertruck explosion
-
News1 week ago
Photos: Pacific Palisades Wildfire Engulfs Homes in an L.A. Neighborhood
-
Education1 week ago
Four Fraternity Members Charged After a Pledge Is Set on Fire
-
Politics1 week ago
Trump trolls Canada again, shares map with country as part of US: 'Oh Canada!'
-
Technology6 days ago
Amazon Prime will shut down its clothing try-on program
-
News1 week ago
Mapping the Damage From the Palisades Fire